Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;2013:762012.
doi: 10.1155/2013/762012. Epub 2013 Sep 26.

Correlates of Adverse Outcomes in Abdominally Obese Individuals: Findings From the Five-Year Followup of the Population-Based Study of Health in Pomerania

Free PMC article

Correlates of Adverse Outcomes in Abdominally Obese Individuals: Findings From the Five-Year Followup of the Population-Based Study of Health in Pomerania

Nele Friedrich et al. J Obes. .
Free PMC article


Background: Abdominal obesity is a major risk factor of cardiovascular disease (CVD), type 2 diabetes (T2DM), and premature death. However, it has not been resolved which factors predispose for the development of these adverse obesity-related outcomes in otherwise healthy individuals with abdominal obesity.

Methods: We studied 1,506 abdominal obese individuals (waist-to-height ratio (WHtR) ≥ 0.5) free of CVD or T2DM from the population-based Study of Health in Pomerania and assessed the incidence of CVD or T2DM after a five-year followup. Logistic regression models were adjusted for major cardiovascular risk factors and liver, kidney diseases, and sociodemographic status.

Results: During follow-up time, we observed 114 and 136 new T2DM and CVD cases, respectively. Regression models identified age, waist circumference, serum glucose, and liver disease as predictors of T2DM. Regarding CVD, only age, unemployment, and a divorced or widowed marital status were significantly associated with incident CVD. In this subgroup of obese individuals blood pressure, serum glucose, or lipids did not influence incidence of T2DM or CVD.

Conclusion: We identified various factors associated with an increased risk of incident T2DM and CVD among abdominally obese individuals. These findings may improve the detection of high-risk individuals and help to advance prevention strategies in abdominal obesity.


Figure 1
Figure 1
Incidence of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) depending on important risk factors including liver disease (only for diabetes), hypertension (only for CVD), increased total cholesterol—high-density lipoprotein cholesterol ratio (TC/HDL-C > 5), and increased glucose levels (>6 mmol/L).

Similar articles

See all similar articles

Cited by 3 articles


    1. De Gonzalez AB, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. New England Journal of Medicine. 2010;363(23):2211–2219. - PMC - PubMed
    1. Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. The Lancet. 2011;377(9771):1085–1095. - PMC - PubMed
    1. Blüher M. The distinction of metabolically “healthy” from “unhealthy” obese individuals. Current Opinion in Lipidology. 2010;21(1):38–43. - PubMed
    1. Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes and Metabolism. 2004;30(6):569–572. - PubMed
    1. Durward CM, Hartman TJ, Nickols-Richardson SM. All-cause mortality risk of metabolically healthy obese individuals in NHANES III. Journal of Obesity. 2012;2012:12 pages.460321 - PMC - PubMed

Publication types

MeSH terms